AIMD Logo

Ainos, Inc. (AIMD) 

NASDAQ
Market Cap
$6.24M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
518 of 960
Rank in Industry
280 of 550

Largest Insider Buys in Sector

AIMD Stock Price History Chart

AIMD Stock Performance

About Ainos, Inc.

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation …

Insider Activity of Ainos, Inc.

Over the last 12 months, insiders at Ainos, Inc. have bought $0 and sold $0 worth of Ainos, Inc. stock.

On average, over the past 5 years, insiders at Ainos, Inc. have bought $400,388 and sold $300,000 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 61,157 shares for transaction amount of $48,559 was made by lee ting-chuan (director) on 2023‑04‑26.

List of Insider Buy and Sell Transactions, Ainos, Inc.

2023-04-26Purchasedirector
61,157
0.7485%
$0.79$48,559-25.61%
2023-04-19Sale10 percent owner
400,000
4.6242%
$0.75$300,000-22.86%
2021-12-21PurchaseCHIEF EXECUTIVE OFFICER
333,986
2.574%
$0.50$166,993-44.82%
2021-12-20Purchasedirector
142,918
1.1015%
$0.50$71,459-32.00%
2021-12-06Purchasedirector
4M
15.414%
$0.25$1M-15.56%
2021-12-06Purchasedirector
150,000
4.6242%
$2.00$300,000-15.56%
2020-10-12PurchasePresident,Chairman,CEO,CFO
400
0.0009%
$0.14$56+216.44%
2020-10-09PurchasePresident,Chairman,CEO,CFO
300
0.0006%
$0.14$41+253.33%
2020-10-08PurchasePresident,Chairman,CEO,CFO
400
0.0008%
$0.13$52+307.69%
2020-10-05PurchasePresident,Chairman,CEO,CFO
200
0.0007%
$0.22$44+112.00%
2020-09-28PurchasePresident,Chairman,CEO,CFO
300
0.0008%
$0.18$54+140.42%
2020-09-22PurchasePresident,Chairman,CEO,CFO
200
0.0006%
$0.20$40+163.73%
2020-09-21PurchasePresident,Chairman,CEO,CFO
800
0.002%
$0.16$128+222.57%
2020-09-17PurchasePresident,Chairman,CEO,CFO
100
0.0003%
$0.22$22+117.51%
2020-09-11PurchasePresident,Chairman,CEO,CFO
100
0.0003%
$0.18$18+116.55%
2020-09-03PurchasePresident,Chairman,CEO,CFO
300
0.001%
$0.21$63+142.86%
2020-09-02PurchasePresident,Chairman,CEO,CFO
200
0.0006%
$0.21$42+124.38%
2020-08-27PurchasePresident,Chairman,CEO,CFO
100
0.0003%
$0.21$21+120.77%
2020-08-24PurchasePresident,Chairman,CEO,CFO
100
0.0003%
$0.21$21+137.50%
2020-08-19PurchasePresident,Chairman,CEO,CFO
300
0.001%
$0.21$63+104.55%

Insider Historical Profitability

<0.0001%
Paul Tibbits
9417696
68.0528%
$0.45400
chang wen-handirector
4000000
28.9042%
$0.4510
MUELLER PETER ROBERTCOO & DIRECTOR OF RESEARCH
1163186
8.4053%
$0.4531
CHEN STEPHEN TPresident,Chairman,CEO,CFO
783000
5.658%
$0.453513
CUMMINS JOSEPH MPRES,CEO,CHAIRMAN OF THE BOARD
781724
5.6488%
$0.45747

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.